Fil LTD Halozyme Therapeutics, Inc. Transaction History

Fil LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$36.46 - $44.03 $7.55 Million - $9.11 Million	-207,002 Reduced 84.09%	39,161 $1.5 Million
Q2 2023 Aug 11, 2023	SELL	$30.28 - $38.74 $7.35 Million - $9.41 Million	-242,773 Reduced 49.65%	246,163 $8.88 Million
Q1 2023 May 11, 2023	SELL	$32.86 - $55.7 $7.85 Million - $13.3 Million	-238,914 Reduced 32.82%	488,936 $18.7 Million
Q4 2022 Feb 13, 2023	SELL	$40.06 - $59.44 $10.9 Million - $16.2 Million	-272,719 Reduced 27.26%	727,850 $41.4 Million
Q3 2022 Nov 10, 2022	BUY	$38.53 - $51.78 $38.6 Million - $51.8 Million	1,000,569 New	1,000,569 $39.6 Million

542

125M

294K

180K

Ticker HALO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 139,288,992
Market Cap $7.35B
Description
Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...

Get notified when there are updates to the investment portfolio of Fil LTD, based on Form 13F filings with the SEC.

Stay updated on Fil LTD with notifications on news.